Between Bedside and Bench | Published:

Shedding pounds after going under the knife: Guts over glory—why diets fail

Nature Medicine volume 18, pages 666667 (2012) | Download Citation

Losing weight can pose a challenge, but how to avoid putting those pounds back on can be a real struggle. A major health problem for obese people is that diseases linked to obesity, such as type 2 diabetes and cardiovascular disease, put their lives at risk, even in young individuals. Although bariatric surgery—a surgical method to reduce or modify the gastrointestinal tract—was originally envisioned for the most severe cases of obesity, evidence suggests that the benefit of this procedure may not be limited to the staggering weight loss it causes. Endogenous factors released from the gut, and modified after surgery, may explain why bariatric surgery can be beneficial for obesity-related diseases and why operated individuals successfully maintain the weight loss. In 'Bedside to Bench,' Rachel Larder and Stephen O'Rahilly peruse a human study with dieters who regained weight despite a successful diet. Appetite-regulating hormones in the gut may be responsible for this relapse in the long term. In 'Bench to Bedside,' Keval Chandarana and Rachel Batterham examine how two different methods of bariatric surgery highlight the relevance of gut-derived hormones not only in inducing sustained weight loss but also in improving glucose homeostasis. These insights may open new avenues to bypass the surgery and obtain the same results with targeted drugs.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Nature 404, 635–643 (2000).

  2. 2.

    Nature 462, 307–314 (2009).

  3. 3.

    et al. J. Am. Med. Assoc. 292, 1724–1737 (2004).

  4. 4.

    et al. Am. J. Clin. Nutr. 74, 579–584 (2001).

  5. 5.

    et al. N. Engl. J. Med. 365, 1597–1604 (2011).

  6. 6.

    , & Cell 129, 251–262 (2007).

  7. 7.

    & Rev. Endocr. Metab. Disord. 12, 235–243 (2011).

  8. 8.

    et al. Am. J. Clin. Nutr. 88, 906–912 (2008).

  9. 9.

    et al. N. Engl. J. Med. 357, 741–752 (2007).

  10. 10.

    , & Trends Endocrinol. Metab. 21, 337–344 (2010).

  11. 11.

    et al. Diabetes 60, 810–818 (2011).

  12. 12.

    , & Nutrition 24, 832–842 (2008).

  13. 13.

    et al. J. Gastrointest. Surg. 13, 1762–1772 (2009).

  14. 14.

    , & Clin. Pharmacol. Ther. 90, 40–51 (2011).

Download references

Author information

Affiliations

  1. Rachel Larder and Stephen O'Rahilly are at Metabolic Research Laboratories, Institute of Metabolic Science, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.

    • Rachel Larder
    •  & Stephen O'Rahilly

Authors

  1. Search for Rachel Larder in:

  2. Search for Stephen O'Rahilly in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Stephen O'Rahilly.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm.2747

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing